1-(2-Nitro-5-((6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanamido)methyl)phenyl)ethyl (3-azidopropyl)carbamate

Catalog No. :
ACWAPW154
CAS No. :
1260247-47-9
Molecular Formula :
C29H43N9O7S
Molecular Weight :
661.79

IUPAC Name:1-(2-nitro-5-((6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanamido)methyl)phenyl)ethyl (3-azidopropyl)carbamate

1-(2-Nitro-5-((6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanamido)methyl)phenyl)ethyl (3-azidopropyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-Nitro-5-((6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanamido)methyl)phenyl)ethyl (3-azidopropyl)carbamate
IUPAC Name1-(2-nitro-5-((6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanamido)methyl)phenyl)ethyl (3-azidopropyl)carbamate
Molecular FormulaC29H43N9O7S
Molecular Weight661.79
SMILESCC(OC(=O)NCCCN=[N+]=[N-])C1=CC(CNC(=O)CCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)=CC=C1[N+](=O)[O-]
InChI KeyXPRFAKAWUTZXMM-SGVKQOAASA-N
CAS No.1260247-47-9

Synthetic Route by SureRoute

1. ACWAPW154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWAPW154 route product structure diagram
    ACWAPW1541260247-47-9
Inquiry

2. ACWAPW154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBWUK036 route compound structure diagram
    ACBWUK03658-85-5 In Stock
  4. Then
  5. ACWAPW154 route product structure diagram
    ACWAPW1541260247-47-9
Inquiry

Comments (0)